tiprankstipranks
Trending News
More News >

AngioDynamics Secures $25M Credit Facility with JPMorgan

Story Highlights
  • AngioDynamics secured a $25 million revolving credit facility with JPMorgan Chase Bank.
  • The credit facility provides financial flexibility for AngioDynamics’ strategic growth and manufacturing process.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
AngioDynamics Secures $25M Credit Facility with JPMorgan

Don’t Miss TipRanks’ Half-Year Sale

AngioDynamics ( (ANGO) ) has provided an update.

On May 28, 2025, AngioDynamics, Inc. entered into a new Credit Agreement with JPMorgan Chase Bank, N.A., securing a $25 million revolving credit facility. This agreement is intended to provide financial flexibility for the company during its manufacturing transfer process, supporting its strategic growth without impacting its operations. The facility includes a maturity date of May 28, 2027, and is secured by the company’s assets, with specific financial covenants and guarantees from its subsidiary, RITA Medical Systems, LLC.

The most recent analyst rating on (ANGO) stock is a Buy with a $14.00 price target. To see the full list of analyst forecasts on AngioDynamics stock, see the ANGO Stock Forecast page.

Spark’s Take on ANGO Stock

According to Spark, TipRanks’ AI Analyst, ANGO is a Neutral.

AngioDynamics’ overall stock score reflects significant financial challenges, including declining revenues and cash flow issues, which are partially offset by the company’s strategic focus in MedTech and promising guidance. Technical indicators suggest a neutral to slightly bearish trend, while the valuation poses risks with a negative P/E ratio. The positive earnings call and raised guidance offer some optimism, but persistent financial and operational challenges weigh on the stock’s potential.

To see Spark’s full report on ANGO stock, click here.

More about AngioDynamics

AngioDynamics, Inc. operates in the medical device industry, focusing on the development and manufacturing of minimally invasive medical devices. The company primarily offers products for vascular access, peripheral vascular disease, and oncology, targeting healthcare providers and hospitals.

Average Trading Volume: 477,519

Technical Sentiment Signal: Hold

Current Market Cap: $394.3M

For an in-depth examination of ANGO stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1